Search

everythinglearnresearchcommunity

for

Search:↓

Adrenal disorders can cause lasting brain and behavior issues in children.

EVG staining is a valuable, simple, and cost-effective method for diagnosing various skin conditions in dermatopathology.

Short anagen syndrome involves a hair growth phase lasting 1.5 years.

Certain DNA variants can predict straight hair in Europeans but are not highly specific.

The skin is a complex barrier that protects the body, regulates temperature, and helps with immune responses.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

KFSD is a genetic disorder causing hair loss and skin issues, with no effective treatment.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Gata6 is important for protecting hair growth cells from DNA damage and keeping normal hair growth.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Dying cells can help with faster healing and new hair growth by releasing a growth-promoting molecule.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Mutations in the HEPHL1 gene cause abnormal hair and cognitive issues.

Balding people may have higher heart disease risk.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Mice with LSS deficiency showed hair loss and cataracts, similar to humans, and can help in understanding and treating this condition.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Tissue stiffness affects hair follicle regeneration, and Twist1 is a key regulator.